Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- CNS Tumors
- Atypical Teratoid/Rhabdoid Tumor (AT/RT)
- Ewing's Family Tumors
- Germ Cell Tumors
- Hepatoblastoma
- Medulloblastoma
- Primary Malignant Brain Neoplasms
- Renal Tumors
- Retinoblastoma
- Rhabdomyosarcoma
- Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)
- Soft Tissue Sarcoma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01505569
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ashish Gupta, MBBS, MPH Masonic Cancer Center, University of Minnesota